FDA approval action for a sodium bicarbonate intravenous solution; regulatory records do not report clinical trial efficacy or comparative outcomes.
Reported
Approval date2026-07-06
Formulation strength50 mEq/50 mL
Concentration1 mEq/mL
Company
1 development in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
FDA approval action for a sodium bicarbonate intravenous solution; regulatory records do not report clinical trial efficacy or comparative outcomes.